Skip to content
GLP-1 Scorecard
Menu
Site position #354

Aurelius Health Group

Published by GLP-1 ScorecardUpdated

Aurelius Health Group is a telehealth platform built around compounded tirzepatide microdosing — a low-dose dual GIP/GLP-1 protocol rather than standard full-dose therapy — with optional NAD+, L-carnitine, B12, or inositol add-ons.

Visit Aurelius Health GroupWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
Not disclosed
Tirzepatide
$199/mo (microdose tier, compounded)
Coverage
Coverage not published
Brand-name
Not confirmed

Line Aurelius Health Group up against its closest alternatives. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value54/100
Dose & formulation52/100
Clinical oversight76/100
Labs & monitoring63/100
Fulfillment61/100
Contract terms61/100

Strengths

  • Pricing fully published and bundled: $89 first month, then $199/mo all-in — more transparent than most compounded brands
  • LegitScript Certified
  • Care-inclusive model: consults, monthly monitoring, and secure messaging rather than Rx-only
  • Unusually candid about the limited evidence base for microdosing

What to consider

  • The advertised $89 is a first-month new-patient rate; every month after it is $199
  • This is a 1 mg microdose program and nothing else — no labeled therapeutic dose is sold, so it is not an alternative to a full-dose prescription
  • No state count is published, only 'most US states', confirmed at intake
  • The site's own comparison table calls 2.4 mg/week the tirzepatide 'standard full dose'; 2.4 mg is the semaglutide maintenance dose, and tirzepatide is labeled 2.5-15 mg/week
  • Compounded tirzepatide is not an FDA-approved finished product

Bottom line — Grade C

Best for: Shoppers who want transparent, care-inclusive compounded tirzepatide microdosing.

Site position #354 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

Closest here

The rankings grading nearest Aurelius Health Group — the realistic shortlist.

The 18 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect Aurelius Health Group's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Aurelius Health Group's site. Not medical advice; see our disclosure.

← Back to the scorecard